The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUC.L Regulatory News (NUC)

  • There is currently no data for NUC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [NUCLEUS FINANCIAL GROUP PLC]

13 Apr 2021 09:48

RNS Number : 2846V
ODDO BHF Asset Management SAS
13 April 2021
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

ODDO BHF Asset Management SAS

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NUCLEUS FINANCIAL GROUP PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

12/04/2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0,10 p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1 954 044

2.56%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

1 954 044

2.56%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

0,10 p ordinary

Purchase

32 755

185 GBp

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 (c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

13/04/2021

Contact name:

Lou PINHEIRO DE ABREU

 

+33 1 44 51 81 38

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSFMSADEFSELL
Date   Source Headline
3rd Dec 202011:07 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
2nd Dec 20205:35 pmRNSStatement re Nucleus Financial Group plc
2nd Dec 202012:07 pmRNSStatement regarding a Possible Offer
17th Nov 20207:00 amRNSDirector/PDMR Shareholding
2nd Nov 20207:00 amRNSAcquisition of certain assets of OpenWealth
23rd Oct 20207:00 amRNSQ3 2020 AUA update
13th Oct 20201:35 pmRNSDirector/PDMR Shareholding
28th Sep 202012:18 pmRNSDirector/PDMR Shareholding
15th Sep 20209:26 amRNSDirector/PDMR Shareholding
8th Sep 20207:00 amRNSInterim Results
14th Aug 20207:00 amRNSNotice of Interim Results
14th Aug 20207:00 amRNSDirector/PDMR Shareholding
24th Jul 20207:00 amRNSQ2 2020 AUA update
14th Jul 20207:00 amRNSDirector/PDMR Shareholding
16th Jun 202012:10 pmRNSDirector/PDMR Shareholding
20th May 20203:44 pmRNSGrant of long term incentive awards
20th May 20201:14 pmRNSResult of AGM
14th May 20207:00 amRNSDirector/PDMR Shareholding
15th Apr 20204:13 pmRNSNotice of AGM
15th Apr 20202:15 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSFinal Results
23rd Mar 20204:40 pmRNSCovid-19 and trading update
17th Mar 20202:28 pmRNSDirector/PDMR Shareholding
26th Feb 20207:00 amRNSNon-Executive Director Changes
13th Feb 20204:15 pmRNSDirector/PDMR Shareholding
31st Jan 20207:00 amRNSQ4 2019 AUA update
29th Jan 20202:20 pmRNSHolding(s) in Company
15th Jan 20203:43 pmRNSDirector/PDMR Shareholding
16th Dec 20192:37 pmRNSDirector/PDMR Shareholding
22nd Nov 20193:50 pmRNSDirector/PDMR Shareholding
14th Nov 201912:00 pmRNSDirector/PDMR Shareholding
25th Oct 20197:00 amRNSQ3 2019 AUA update
18th Oct 20195:38 pmRNSDirector/PDMR Shareholding
16th Oct 201911:15 amRNSDirector/PDMR Shareholding
17th Sep 20194:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
16th Aug 20197:00 amRNSNotice of Results
15th Aug 20193:58 pmRNSDirector/PDMR Shareholding
26th Jul 20197:00 amRNSQ2 2019 AUA update
16th Jul 20199:00 amRNSDirector/PDMR Shareholding
14th Jun 20194:48 pmRNSDirector/PDMR Shareholding
23rd May 201911:35 amRNSResult of AGM
17th May 20197:00 amRNSDirector/PDMR Shareholding
29th Apr 20197:00 amRNSQ1 2019 AUA update
16th Apr 20191:58 pmRNSDirector/PDMR Shareholding
11th Apr 20192:24 pmRNSPosting of Annual Report and Notice of AGM
4th Apr 20198:20 amRNSHolding(s) in Company
3rd Apr 20191:50 pmRNSGrant of long term incentive awards to PDMRs
2nd Apr 20197:00 amRNSPreliminary results
14th Mar 20194:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.